| Total (N = 400) |
---|---|
Age | 58 (52, 63) |
Gender (%) | Â |
Men | 49 |
Women | 51 |
Race (%) | Â |
White | 58 |
Black | 36 |
Other | 6 |
Hypertension (%) | 73 |
Systolic BP (mmHg) | 128 (118, 136) |
Diastolic BP (mmHg) | 75 (70, 80) |
Waist Circumference (in) | 42 (38, 46) |
BMI (kg/m2) | 31.7 (28.0, 36.2) |
Glucose (mg/dL) | 112 (95, 139) |
Hemoglobin A1c (%) | 6.7 (6.2, 7.5) |
Serum Creatinine (mg/dL) | 0.88 (0.70, 1.0) |
BUN (mg/dL) | 16 (13, 19) |
eGFR (CKD-EPI) | 91.7 (80.0, 102.1) |
Urinary ACR (mg/g) | 5.3 (3, 13.5) |
Anti-Hypertensive Medications (%) | Â |
ACE Inhibitor or ARB | 61 |
Diuretic | 32 |
CCB | 16 |
Beta Blocker | 12 |
Lipid-Lowering Medications (%) | Â |
Statin | 52 |
Fibrate | 7 |
Niacin | 4 |
Lp(a) (mg/dL) | 25 (9, 57) |
ApoC-III (mg/dL)* | 11.4 (8.7, 15.6) |
Triglycerides (mg/dL) | 105 (79, 156) |
LDL-C (mg/dL) | 99 (79, 119) |
Apolipoprotein B (mg/dL) | 80 (69, 94) |